Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 10557
Country/Region: Ethiopia
Year: 2016
Main Partner: Mekelle University
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $693,107 Additional Pipeline Funding: $87,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Health Systems Strengthening (OHSS) $134,268
Testing: HIV Testing and Counseling (HVCT) $15,411
Sexual Prevention: Other Sexual Prevention (HVOP) $86,925
Treatment: Adult Treatment (HTXS) $430,786
Treatment: Pediatric Treatment (PDTX) $25,717
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 60
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 44
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 66
GEND_GBV Number of people receiving post-GBV care 2017 110
HRH_PRE By Graduates: Doctors 2017 126
HRH_PRE Number of new HCW who graduated from a pre-service training institution or program as a result of PEPFAR-supported strengthening efforts, within the reporting period, by select cadre 2017 126
HRH_PRE Sum of Graduates disaggregates 2017 126
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 32
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 32
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 2,928
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 158
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 3,150
HTS_TST Service Delivery Point (Facility): Other PITC 2017 1,574
HTS_TST Service Delivery Point (Facility): Outpatient 2017 473
HTS_TST Service Delivery Point (Facility): VCT 2017 1,103
HTS_TST Sum of Aggregated Age/Sex <15 2017 64
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 3,086
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 3,150
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 2
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 2
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 122
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 10
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 3,759
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 3,759
KP_PREV Total estimated number of key population in the catchment area 2017 4,134
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 4,134
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 1,000
TX_CURR Aggregated Age/Sex: <15 Female 2017 136
TX_CURR Aggregated Age/Sex: <15 Male 2017 135
TX_CURR Aggregated Age/Sex: 15+ Female 2017 1,378
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,025
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 2,674
TX_CURR Sum of Aggregated Age/Sex <15 2017 271
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 2,403
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 2,674
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 18
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 22
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 347
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 138
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 525
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 525
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 1,734
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 1,387
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 71
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 70
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 715
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 531
TX_PVLS Numerator: Indication: Routine 2017 1,110
TX_PVLS Numerator: Indication: Targeted 2017 277
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 88
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 88
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 893
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 665
TX_PVLS_den Denominator: Indication: Routine 2017 1,387
TX_PVLS_den Denominator: Indication: Targeted 2017 347
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 9
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 86
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 47
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 150
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 173
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 9
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 10
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 99
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 55
Cross Cutting Budget Categories and Known Amounts Total: $266,016
Human Resources for Health $134,268
Gender: Gender Based Violence (GBV) $10,000
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Food and Nutrition: Commodities $121,748